WM Q3 revenue rises 14.9% to $6.4 billion, but GAAP EPS falls to $1.49
WM reported third-quarter 2025 revenue of $6.443 billion, up 14.9% from $5.609 billion a year earlier, with growth including the WM Healthcare Solutions business acquired through Stericycle. GAAP diluted EPS fell to $1.49 from $1.88, while adjusted diluted EPS rose to $1.98 from $1.96, and the company affirmed its full-year adjusted operating EBITDA and free cash flow guidance but expects 2025 revenue at the low end of its prior range.
Key points
- Q3 2025 GAAP diluted EPS was $1.49 versus $1.88 a year earlier; adjusted diluted EPS was $1.98 versus $1.96.
- Q3 income from operations was $989 million, down from $1.119 billion, including a $213 million loss from divestitures, asset impairments and unusual items.
- 2025 adjusted operating EBITDA guidance of $7.475 billion to $7.625 billion and free cash flow guidance of $2.8 billion to $2.9 billion were affirmed.
- Full-year 2025 revenue is now expected at about $25.275 billion, the low end of prior guidance, mainly due to lower recycled commodity prices and lower WM Healthcare Solutions revenue expectations.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 27, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.